# EDGAR Filing Document

**Accession Number:** 0001412558
**File Stem:** 0001654954-23-003689
**Filing Date:** 2023-3
**Character Count:** 4681
**Document Hash:** 4e252db9a28924a378771b8ebb9720e8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-23-003689.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001654954-23-003689

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 68

**CONFORMED PERIOD OF REPORT**: 20230328

**FILED AS OF DATE**: 20230328

**DATE AS OF CHANGE**: 20230328

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Evotec SE
- **CENTRAL INDEX KEY:** 0001412558
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** 2M
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34041
- **FILM NUMBER:** 23766883

**BUSINESS ADDRESS:**
- **STREET 1:** ESSENER BOGEN 7
- **CITY:** HAMBURG
- **STATE:** 2M
- **ZIP:** 22419
- **BUSINESS PHONE:** 49-40-560-810

**MAIL ADDRESS:**
- **STREET 1:** ESSENER BOGEN 7
- **CITY:** HAMBURG
- **STATE:** 2M
- **ZIP:** 22419

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Evotec AG
- **DATE OF NAME CHANGE:** 20070917

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE MONTH OF MARCH 2023**

**COMMISSION FILE NUMBER 001-34041**

---

| |
|:---|
| **Evotec SE** |
| (Translation of registrant's name into English) |

---

**Essener Bogen 7**

**22419 Hamburg**

**Germany**

**Tel: +49 40 560810** 

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

On March 28, 2023, Evotec SE (the "Company") announced preliminary financial results and corporate updates for the fiscal year ended 31 December 2022. The press release is attached hereto as Exhibit 99.1. An accompanying analyst presentation is attached hereto as Exhibit 99.2

**SIGNATURE**

Pursuant to the requirements of s the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Evotec SE** | **Evotec SE** |
|  | By: | /s/ Enno Spillner |
|  |  | Name: Enno Spillner |
|  |  | Title: Chief Financial Officer |
| Date: March 28, 2023 |  |  |

---

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit** | **Description of Exhibit** |
| [99.1](evo_ex991.htm) | [Evotec SE preliminary fiscal year 2022 results: "Ahead of the curve" – very strong performance in a challenging year](evo_ex991.htm) |
| [99.2](evo_ex992.htm) | [Evotec SE: Ahead of the curve – Leadership in our focus areas for medicines that matter](evo_ex992.htm) |

---

## Exhibit 99.1

**EXHIBIT 99.1**

![](evo_ex991img1.jpg)

![](evo_ex991img2.jpg)

![](evo_ex991img3.jpg)

![](evo_ex991img4.jpg)

![](evo_ex991img5.jpg)

![](evo_ex991img6.jpg)

![](evo_ex991img7.jpg)

![](evo_ex991img8.jpg)

## Exhibit 99.2

**EXHIBIT 99.2**

![](evo_ex992img58.jpg)

![](evo_ex992img59.jpg)

![](evo_ex992img60.jpg)

![](evo_ex992img61.jpg)

![](evo_ex992img62.jpg)

![](evo_ex992img63.jpg)

![](evo_ex992img64.jpg)

![](evo_ex992img65.jpg)

![](evo_ex992img66.jpg)

![](evo_ex992img67.jpg)

![](evo_ex992img68.jpg)

![](evo_ex992img69.jpg)

![](evo_ex992img70.jpg)

![](evo_ex992img71.jpg)

![](evo_ex992img72.jpg)

![](evo_ex992img73.jpg)

![](evo_ex992img74.jpg)

![](evo_ex992img75.jpg)

![](evo_ex992img76.jpg)

![](evo_ex992img77.jpg)

![](evo_ex992img78.jpg)

![](evo_ex992img79.jpg)

![](evo_ex992img80.jpg)

![](evo_ex992img81.jpg)

![](evo_ex992img82.jpg)

![](evo_ex992img83.jpg)

![](evo_ex992img84.jpg)

![](evo_ex992img85.jpg)

![](evo_ex992img86.jpg)

![](evo_ex992img87.jpg)

![](evo_ex992img88.jpg)

![](evo_ex992img89.jpg)

![](evo_ex992img90.jpg)

![](evo_ex992img91.jpg)

![](evo_ex992img92.jpg)

![](evo_ex992img93.jpg)

![](evo_ex992img94.jpg)

![](evo_ex992img95.jpg)

![](evo_ex992img96.jpg)

![](evo_ex992img97.jpg)

![](evo_ex992img98.jpg)

![](evo_ex992img99.jpg)

![](evo_ex992img100.jpg)

![](evo_ex992img101.jpg)

![](evo_ex992img102.jpg)

![](evo_ex992img103.jpg)

![](evo_ex992img104.jpg)

![](evo_ex992img105.jpg)

![](evo_ex992img106.jpg)

![](evo_ex992img107.jpg)

![](evo_ex992img108.jpg)

![](evo_ex992img109.jpg)

![](evo_ex992img110.jpg)

![](evo_ex992img111.jpg)

![](evo_ex992img112.jpg)

![](evo_ex992img113.jpg)

![](evo_ex992img114.jpg)